About 26% discontinued GLP-1 therapy over three years, and another 23% had interruptions in treatment
Diabetologia 65(Suppl 1):S290S291 Gastaldelli A, Cusi K, Fernandez Lando L, Bray R, Brouwers B, Rodriguez A (2022) Effect of tirzepatide versus insulin degludec on liver fat content and abdominal adipose tissue in people with type 2 diabetes (SURPASS-3 MRI): a substudy of the randomised, open-label, parallel-group, phase 3 SURPASS-3 trial
JAMA Network+3MDPI+3ScienceDirect+3 Why Alzheimers has been called type 3 diabetes For more than a decade, researchers have observed that insulin signaling in the brain is impaired in Alzheimers disease (AD)
The body produces its own glutathione, but levels may be depleted by poor diet, pollution, toxins, stress, ageing and infections